Biblioteca Virtual en Salud - México

621 referencias bibliográficas encontradas en Biblioteca Virtual en Salud México

6201Wolff M, Fich F, Acuna G, Vial P, Wu E, Ripoll E, Gomez P, Morales OAntiretroviral therapy. Announcement of the Advisory Committee of the Chilean Society of Infectology on AIDSRev Med Chil 1998 May;126(5):577-81
6202Crystal S, Sambamoorthi U, Merzel CThe diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohortsHealth Serv Res 1995 Oct;30(4):593-614
6203Schindzielorz A, Pike I, Daniels M, Pacelli L, Smaldone LRates and risk factors for adverse events associated with didanosine in the expanded access programClin Infect Dis 1994 Dec;19(6):1076-83
6205Holmberg SD, Conley LJ, Buchbinder SP, Judson FN, Bush TJ, Katz MH, Penley KA, Hershow RCUse of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US citiesAIDS 1993 May;7(5):699-704
6206Easterbrook PJ, Keruly JC, Creagh-Kirk T, Richman DD, Chaisson RE, Moore RDRacial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study GroupJAMA 1991 Nov 20;266(19):2713-8
6209Booth RE, Kwiatkowski CF, Stephens RCEffectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug usersJ Psychoactive Drugs 1998 Jul-Sep;30(3):269-78
6210Diaz T, Chu SY, Weinstein B, Mokotoff E, Jones TSInjection and syringe sharing among HIV-infected injection drug users: implications for prevention of HIV transmission. Supplement to HIV/AIDS Surveillance GroupJ Acquir Immune Defic Syndr Hum Retrovirol 1998;18 Suppl 1:S76-81
6218Valimaki M, Suominen T, Peate IAttitudes of professionals, students and the general public to HIV/AIDS and people with HIV/AIDS: a review of the research.J Adv Nurs 1998 Apr;27(4):752-9
6219Bennett L, Rose D, Jackson A, Thomas SPsychological and socio-medical aspects of HIV/AIDS: a reflection on publications in AIDS care (1989-1995).AIDS Care 1998 Feb;10(1):115-21
6220Hang G, Xu J, Gong ZA study on AIDS-related knowledge, attitude and behavior in servicemen in ChinaChung Hua Yu Fang I Hsueh Tsa Chih 1996 Mar;30(2):94-7
6222Whalen CK, Henker B, O'Neil R, Hollingshead J, Holman A, Moore BPreadolescents' perceptions of AIDS before and after Earvin Magic Johnson's announcement.J Pediatr Psychol 1994 Feb;19(1):3-17; discussion 19-26
6223Soni SD, Windgassen EAIDS panic: effects of mass media publicity.Acta Psychiatr Scand 1991 Aug;84(2):121-4
6226Bratt G, Karlsson A, Leandersson AC, Albert J, Wahren B, Sandstrom ETreatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.AIDS 1998 Nov 12;12(16):2193-202
6229Rozenbaum WThe concept of therapeutic management: exemplary implementation of antiretroviral treatmentsPresse Med 1998 May 23-30;27(19):919-20
6231Sherer RCurrent antiretroviral therapy and its impact on human immunodeficiency virus-related wasting.Semin Oncol 1998 Apr;25(2 Suppl 6):92-7
6235Tan B, Ratner LThe use of new antiretroviral therapy in combination with chemotherapy.Curr Opin Oncol 1997 Sep;9(5):455-64
6237Letvin-NLProgress in the development of an HIV-1 vaccine.Science. 1998 Jun 19; 280(5371): 1875-80
6239Ruprecht-RM; Baba-TW; Liska-V; Ayehunie-S; Andersen-J; Montefiori-DC; Trichel-A; Murphey-Corb-M; Martin-L; Rizvi-TA; Bernacky-BJ; Buchl-SJ; Keeling-MOral SIV, SHIV, and HIV type 1 infection.AIDS-Res-Hum-Retroviruses. 1998 Apr; 14 Suppl 1: S97-103
6241Clements-Mann-ML; Weinhold-K; Matthews-TJ; Graham-BS; Gorse-GJ; Keefer-MC; McElrath-MJ; Hsieh-RH; Mestecky-J; Zolla-Pazner-S; Mascola-J; Schwartz-D;Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.J-Infect-Dis. 1998 May; 177(5): 1230-46
6244Gorse-GJ; McElrath-MJ; Matthews-TJ; Hsieh-RH; Belshe-RB; Corey-L; Frey-SE; Kennedy-DJ; Walker-MC; Eibl-MMModulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.Vaccine. 1998 Mar; 16(5): 493-506

anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 siguiente


© Instituto Nacional de Salud Pública - CENIDS 2005